A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT07499232 · RECRUITING
Trial details
- NCT number
- NCT07499232
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2028-11-15
- Enrollment
- 530
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.